Moreover, in patients with T2DM receiving metformin, genetic variations in the solute carrier family 22 member 1 (SLC22A1) loci have recently been associated with differential therapeutic responses and variability in glycated hemoglobin (HbA1c) levels [96]. The gene discussed is SLC22A1; the disease is type 2 diabetes mellitus.